Literature DB >> 2668319

Rapid isolation of morbillivirus nucleocapsid for genomic RNA cDNA cloning and the production of specific core protein antisera.

M Oglesbee1, L Tatalick, S Ringler, J Rice, S Krakowka.   

Abstract

A procedure is described for the rapid isolation of canine distemper virus nucleocapsid, free from contaminating viral non-core and host cellular proteins. Nucleocapsid isolated in this manner is amenable to ultrastructural evaluation, protein isolation for the production of monospecific hyperimmune serum, and genomic RNA isolation for cDNA cloning. Nucleocapsid (NC) and a defective NC variant (Df-NC) isolated from 5.5 x 10(7) Vero cells infected with Ond-CDV is readily visualized on cesium gradients. The calculated density for NC is 1.2976 +/- 0.0033 g/ml and 1.2458 +/- 0.0056 g/ml for Df-NC. Ultrastructurally, NC appears as long uninterrupted strands, 1.6 +/- 0.1 microns in length, 21.2 +/- 1.7 nm in diameter, with well defined capsid subunits. Df-NC are truncated with a uniform length of 85.8 +/- 7.1 nm and a 24.5 +/- 1.3 nm diameter. A total of 2.1 +/- 0.2 mu of NC protein is obtained for every 1 x 10(6) cells infected; 89.7% of this mass is represented by a 61 kDa protein (N), 8.4% by a 75 kDa protein (P), and 1.9% by a 160-200 kDa protein (L), which is in agreement with the NC constituency of other paramyxoviruses. Viral N and P proteins, purified by 7.5% SDS-PAGE, were used in the production of hyperimmune serum. Specificity was demonstrated by Western blot analysis. Both antisera were capable of detecting viral antigen in persistently and lytically CDV infected cells by indirect immunofluorescence. A single high molecular weight species of nucleic acid was isolated from purified nucleocapsids compatible with a 14.6 kb morbillivirus genome. Although the efficiency of RNA extraction from purified NC was low (14.2%), sufficient RNA was obtained for gel analysis and the establishment of genomic RNA cDNA clones.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2668319      PMCID: PMC7119570          DOI: 10.1016/0166-0934(89)90040-2

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  38 in total

1.  The synthesis of sendai virus polypeptides in infected cells.

Authors:  R A Lamb; B W Mahy; P W Choppin
Journal:  Virology       Date:  1976-01       Impact factor: 3.616

2.  Monoclonal antibodies to the P protein of Sendai virus define its structure and role in transcription.

Authors:  K L Deshpande; A Portner
Journal:  Virology       Date:  1985-01-15       Impact factor: 3.616

3.  In vitro replication of Sendai virus wild-type and defective interfering particle genome RNAs.

Authors:  S R Carlsen; R W Peluso; S A Moyer
Journal:  J Virol       Date:  1985-05       Impact factor: 5.103

4.  Monoclonal antibodies against five structural components of measles virus. II. Characterization of five cell lines persistently infected with measles virus.

Authors:  H Sheshberadaran; E Norrby; K W Rammohan
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

Review 5.  Pathogenesis of multiple sclerosis. A critical reappraisal.

Authors:  C M Poser
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

6.  A simple and very efficient method for generating cDNA libraries.

Authors:  U Gubler; B J Hoffman
Journal:  Gene       Date:  1983-11       Impact factor: 3.688

7.  Five measles virus antigens demonstrated by use of mouse hybridoma antibodies in productively infected tissue culture cells.

Authors:  E Norrby; S N Chen; T Togashi; H Shesberadaran; K P Johnson
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

8.  Isolation and characterization of subacute sclerosing panencephalitis virus nucleocapsids.

Authors:  J Yeh; Y Iwasaki
Journal:  J Virol       Date:  1972-12       Impact factor: 5.103

9.  Characterization of clones for the sixth (L) gene and a transcriptional map for morbilliviruses.

Authors:  B K Rima; K Baczko; D K Clarke; M D Curran; S J Martin; M A Billeter; V ter Meulen
Journal:  J Gen Virol       Date:  1986-09       Impact factor: 3.891

10.  Intracisternal virus-like particles in brain of a multiple sclerosis patient.

Authors:  R Tanaka; Y Iwasaki; H Koprowski
Journal:  J Neurol Sci       Date:  1976-05       Impact factor: 3.181

View more
  4 in total

1.  Intranuclear inclusions in paramyxovirus-induced encephalitis: evidence for altered nuclear body differentiation.

Authors:  M Oglesbee
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

2.  Insights into the regulatory mechanism controlling the inhibition of vaccine-induced seroconversion by maternal antibodies.

Authors:  Dhohyung Kim; Devra Huey; Michael Oglesbee; Stefan Niewiesk
Journal:  Blood       Date:  2011-02-28       Impact factor: 22.113

3.  Determination of a phosphorylation site in Nipah virus nucleoprotein and its involvement in virus transcription.

Authors:  Mingshu Huang; Hiroki Sato; Kyoji Hagiwara; Akira Watanabe; Akihiro Sugai; Fusako Ikeda; Hiroko Kozuka-Hata; Masaaki Oyama; Misako Yoneda; Chieko Kai
Journal:  J Gen Virol       Date:  2011-05-25       Impact factor: 3.891

4.  Use of surface plasmon resonance for the measurement of low affinity binding interactions between HSP72 and measles virus nucleocapsid protein.

Authors:  Xinsheng Zhang; Michael Oglesbee
Journal:  Biol Proced Online       Date:  2003-09-05       Impact factor: 3.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.